Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00825396
NCT00825396
Completed
Not Applicable

A Pilot, Open-Label, Controlled Clinical Trial of C-KAD Ophthalmic Solution in Reducing Intraocular Pressure in Patients With Ocular Hypertension

Chakshu Research, Inc.1 site in 1 country12 target enrollmentApril 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOcular Hypertension
InterventionsC-KAD Ophthalmic Solution
DrugsC-KAD Ophthalmic Solution

Overview

Phase
Not Applicable
Intervention
C-KAD Ophthalmic Solution
Conditions
Ocular Hypertension
Sponsor
Chakshu Research, Inc.
Enrollment
12
Locations
1
Primary Endpoint
Mean change in intraocular pressure from baseline
Status
Completed
Last Updated
16 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.

Registry
clinicaltrials.gov
Start Date
April 2007
End Date
April 2009
Last Updated
16 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Both eyes having intraocular pressure in the range of 22-30 mmHg at baseline
  • •Both eyes having best corrected visual acuity better than 20/50

Exclusion Criteria

  • •Advanced glaucoma
  • •Closed or barely open anterior chamber or history of angle closure

Arms & Interventions

C-KAD Ophthalmic Solution

Intervention: C-KAD Ophthalmic Solution

Outcomes

Primary Outcomes

Mean change in intraocular pressure from baseline

Time Frame: 150 Days

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Phase 2
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related CataractCataract
NCT00793091Chakshu Research, Inc.80
Unknown
Phase 2
Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear CataractNuclear Cataract
NCT00825721Chakshu Research, Inc.81
Unknown
Phase 2
An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid HyalosisAsteroid Hyalosis
NCT00825942Chakshu Research, Inc.20
Completed
Phase 1
Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10XProliferative Diabetic Retinopathy (PDR)
NCT01869933OcuCure Therapeutics, Inc.10
Completed
Phase 3
Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy VolunteersAllergic Conjunctivitis
NCT01159015Bausch & Lomb Incorporated534